Hepatitis due to human herpesvirus 6B after hematopoietic cell transplantation and a review of the literature

Transplant Infectious Disease

Volumn 16, Issue 3, 2014, Pages 477-483

  Hill, J A ^a,b   Myerson, D ^a,b   Sedlak, R H ^a   Jerome, K R ^a,b   Zerr, D M ^c,d  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b USA   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Hepatitis; Herpesvirus; HHV 6B; HHV6B; Liver; Transplant

Indexed keywords

ALANINE AMINOTRANSFERASE; ALEMTUZUMAB; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CYCLOPHOSPHAMIDE; DAPSONE; FLUDARABINE; FOSCARNET; GANCICLOVIR; METHYLPREDNISOLONE; MICAFUNGIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN V POTASSIUM; PREDNISONE; RAPAMYCIN; STEROID; VALACICLOVIR; VALGANCICLOVIR; VORICONAZOLE; ANTIVIRUS AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADRENAL INSUFFICIENCY; ADULT; ANOREXIA; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CELL TRANSPLANTATION; CHOLECYSTECTOMY; CHOLELITHIASIS; CHRONIC PAIN; COMMON BILE DUCT STONE; CONSTIPATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DAY HOSPITAL; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EPIGASTRIC PAIN; ESOPHAGOGASTRODUODENOSCOPY; FEVER; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HEPATITIS B; HERPES SIMPLEX VIRUS 2; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HYPERTRANSAMINASEMIA; IMMUNIZATION; IRON OVERLOAD; LIVER; LIVER BIOPSY; LIVER TOXICITY; LUNG DISEASE; LUNG NODULE; MALARIA; MALE; MEDICAL EXAMINATION; MICROFILARIASIS; MULTIMODALITY CANCER THERAPY; NAUSEA; OROPHARYNX CANDIDIASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SICKLE CELL; SIGMOIDOSCOPY; TACHYCARDIA; VEIN OCCLUSION; VOMITING; WHOLE BODY RADIATION; YOUNG ADULT; ADVERSE EFFECTS; EXANTHEMA SUBITUM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; PHYSIOLOGY; VIROLOGY; VIRUS HEPATITIS;

ANTIVIRAL AGENTS; GANCICLOVIR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS, VIRAL, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; MALE; ROSEOLOVIRUS INFECTIONS; YOUNG ADULT;

EID: 84901983940     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/tid.12208     Document Type: Article

References (37)

1. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 2005; 18: 217-245.
2. Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352: 768-776.
3. Mori Y, Yang X, Akkapaiboon P, Okuno T, Yamanishi K. Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J Virol 2003; 77: 4992-4999.
4. Zerr DM. Human herpesvirus 6 (HHV-6) disease in the setting of transplantation. Curr Opin Infect Dis 2012; 25: 438-444.
5. Razonable RR. Human herpesviruses 6, 7 and 8 in solid organ transplant recipients. Am J Transplant 2013; 13 (Suppl 3): 67-78.
6. Kuribayashi K, Matsunaga T, Iyama S, et al. Human herpesvirus-6 hepatitis associated with cyclosporine-A encephalitis after bone marrow transplantation for chronic myeloid leukemia. Intern Med 2006; 45: 475-478.
7. Zerr DM, Gupta D, Huang M-L, Carter R, Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 309-317.
8. Sedlak RH, Cook L, Huang ML, et al. Rapid and accurate identification of chromosomally integrated human herpesvirus 6 by droplet digital PCR. Clin Chem 2014; 60(5): 765-772.
9. Flamand L, Komaroff AL, Arbuckle JH, Medveczky PG, Ablashi DV. Review, part 1: human herpesvirus-6-basic biology, diagnostic testing, and antiviral efficacy. J Med Virol 2010; 82: 1560-1568.
10. Amigues I, Cohen N, Chung D, et al. Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16: 46-52.
11. Strasser SI, McDonald GB. Gastrointestinal and hepatic complications. In: Blume KG, Forman SJ, Applebaum FR, eds. Thomas' Hematopoietic Cell Transplantation (3rd edn.). Malden, MA: Wiley-Blackwell, 2004: 769-810.
12. Ma SY, Au WY, Ng IOL, et al. Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication. Transplantation 2004; 77: 1252-1259.
13. Strasser SI, Shulman HM, Flowers ME, et al. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000; 32: 1265-1271.
14. Ahlqvist J, Fotheringham J, Akhyani N, Yao K, Fogdell-Hahn A, Jacobson S. Differential tropism of human herpesvirus 6 (HHV-6) variants and induction of latency by HHV-6A in oligodendrocytes. J Neurovirol 2005; 11: 384-394.
15. Cermelli C, Concari M, Carubbi F, et al. Growth of human herpesvirus 6 in HEPG2 cells. Virus Res 1996; 45: 75-85.
16. Asano Y, Nakashima T, Yoshikawa T, Suga S, Yazaki T. Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum. J Pediatr 1991; 118: 891-895.
17. Ishikawa K, Hasegawa K, Naritomi T, et al. Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. J Gastroenterol 2002; 37: 523-530.
18. Aita K, Jin Y, Irie H, et al. Are there histopathologic characteristics particular to fulminant hepatic failure caused by human herpesvirus-6 infection? A case report and discussion. Hum Pathol 2001; 32: 887-889.
19. Tronconi GM, Mariani B, Pajno R, et al. [Acute liver failure due to human herpesvirus 6 in an infant]. Pediatr Med Chir 2012; 34: 229-233.
20. Tajiri H, Tanaka-Taya K, Ozaki Y, Okada S, Mushiake S, Yamanishi K. Chronic hepatitis in an infant, in association with human herpesvirus-6 infection. J Pediatr 1997; 131: 473-475.
21. Mendel I, de Matteis M, Bertin C, et al. Fulminant hepatitis in neonates with human herpesvirus 6 infection. Pediatr Infect Dis J 1995; 14: 993-997.
22. Sobue R, Miyazaki H, Okamoto M, et al. Fulminant hepatitis in primary human herpesvirus-6 infection. N Engl J Med 1991; 324: 1290.
23. Asano Y, Yoshikawa T, Suga S, Yazaki T, Kondo K, Yamanishi K. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 1990; 335: 862-863.
24. Tajiri H, Nose O, Baba K, Okada S. Human herpesvirus-6 infection with liver injury in neonatal hepatitis. Lancet 1990; 335: 863.
25. Dubedat S, Kappagoda N. Hepatitis due to human herpesvirus-6. Lancet 1989; 2: 1463-1464.
26. Härmä M, Höckerstedt K, Lautenschlager I. Human herpesvirus-6 and acute liver failure. Transplantation 2003; 76: 536-539.
27. Lautenschlager I, Härmä M, Höckerstedt K, Linnavuori K, Loginov R, Taskinen E. Human herpesvirus-6 infection is associated with adhesion molecule induction and lymphocyte infiltration in liver allografts. J Hepatol 2002; 37: 648-654.
28. Feldstein AE, Razonable RR, Boyce TG, et al. Prevalence and clinical significance of human herpesviruses 6 and 7 active infection in pediatric liver transplant patients. Pediatr Transplant 2003; 7: 125-129.
29. Dohna-Schwake C, Fiedler M, Gierenz N, et al. Primary HHV 6 infection after liver transplantation with acute graft rejection and multi-organ failure: successful treatment with a 2.5-fold dose of cidofovir and reduction of immunosuppression. Pediatr Transplant 2011; 15: E126-E129.
30. Griffiths PD, Ait-Khaled M, Bearcroft CP, et al. Human herpesviruses 6 and 7 as potential pathogens after liver transplant: prospective comparison with the effect of cytomegalovirus. J Med Virol 1999; 59: 496-501.
31. Buyse S, Roque-Afonso A-M, Vaghefi P, et al. Acute hepatitis with periportal confluent necrosis associated with human herpesvirus 6 infection in liver transplant patients. Am J Clin Pathol 2013; 140: 403-409.
32. Ljungman P, Wang FZ, Clark DA, et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000; 111: 774-781.
33. Pellett PE, Ablashi DV, Ambros PF, et al. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 2012; 22 (3): 144-155.
34. Akhyani N, Fotheringham J, Yao K, Rashti F, Jacobson S. Efficacy of antiviral compounds in human herpesvirus-6-infected glial cells. J Neurovirol 2006; 12: 284-293.
35. Ishiyama K, Katagiri T, Hoshino T, Yoshida T, Yamaguchi M, Nakao S. Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT. Bone Marrow Transplant 2011; 46: 863-869.
36. Betts BC, Young J-AH, Ustun C, Cao Q, Weisdorf DJ. Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? Biol Blood Marrow Transplant 2011; 17: 1562-1568.
37. Ogata M, Satou T, Inoue Y, et al. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis. Bone Marrow Transplant 2012; 48: 257-264.